Hildebrand K - Search Results

1

Fall risk factors in Parkinson's disease.

Gray P, Hildebrand K. Gray P, et al. Among authors: hildebrand k. J Neurosci Nurs. 2000 Aug;32(4):222-8. doi: 10.1097/01376517-200008000-00006. J Neurosci Nurs. 2000. PMID: 10994536

2

Risperidone in the treatment of dopamine-induced psychosis in Parkinson's disease: an open pilot trial.

Mohr E, Mendis T, Hildebrand K, De Deyn PP. Mohr E, et al. Among authors: hildebrand k. Mov Disord. 2000 Nov;15(6):1230-7. doi: 10.1002/1531-8257(200011)15:6<1230::aid-mds1026>3.0.co;2-9. Mov Disord. 2000. PMID: 11104211 Clinical Trial.

3

Worsening of motor function in Parkinson's disease: a "typical" response to "atypical" antipsychotic medications.

Mohr E, Hildebrand K, Mendis T, De Deyn PP. Mohr E, et al. Among authors: hildebrand k. Neurology. 2001 May 8;56(9):1249-50. doi: 10.1212/wnl.56.9.1249-a. Neurology. 2001. PMID: 11342706 No abstract available.

4

Cerebral metabolic changes in Alzheimer's disease: neurobehavioral patterns.

Blesa R, Mohr E, Miletich RS, Hildebrand K, Sampson M, Chase TN. Blesa R, et al. Among authors: hildebrand k. Dementia. 1996 Sep-Oct;7(5):239-45. doi: 10.1159/000106886. Dementia. 1996. PMID: 8872413 Review.

5

First Real-World Safety Analysis of Preschool Peanut Oral Immunotherapy.

Soller L, Abrams EM, Carr S, Kapur S, Rex GA, Leo S, Lidman PG, Yeung J, Vander Leek TK, McHenry M, Wong T, Cook VE, Hildebrand KJ, Gerstner TV, Mak R, Lee NJ, Cameron SB, Chan ES. Soller L, et al. Among authors: hildebrand kj. J Allergy Clin Immunol Pract. 2019 Nov-Dec;7(8):2759-2767.e5. doi: 10.1016/j.jaip.2019.04.010. Epub 2019 Apr 17. J Allergy Clin Immunol Pract. 2019. PMID: 31002957

6

Changes in cerebral glucose metabolism with normal aging.

Blesa R, Mohr E, Miletich RS, Randolph C, Hildebrand K, Sampson M, Chase TN. Blesa R, et al. Among authors: hildebrand k. Eur J Neurol. 1997 Jan;4(1):8-14. doi: 10.1111/j.1468-1331.1997.tb00294.x. Eur J Neurol. 1997. PMID: 24283817

7

Primum non nocere-first do no harm. And then feed peanut.

Hildebrand KJ, Abrams EM, Vander Leek TK, Upton JEM, Mack DP, Kirste L, McCusker C, Kapur S. Hildebrand KJ, et al. Allergy Asthma Clin Immunol. 2017 Feb 8;13:7. doi: 10.1186/s13223-017-0180-2. eCollection 2017. Allergy Asthma Clin Immunol. 2017. PMID: 28194188 Free PMC article.

8

Extended analysis of parent and child confidence in recognizing anaphylaxis and using the epinephrine autoinjector during oral food challenges.

Soller L, Teoh T, Baerg I, Wong T, Hildebrand KJ, Cook VE, Biggs CM, Lee N, Yaworski L, Cameron SB, Chan ES. Soller L, et al. J Allergy Clin Immunol Pract. 2019 Feb;7(2):693-695. doi: 10.1016/j.jaip.2018.09.025. Epub 2018 Oct 5. J Allergy Clin Immunol Pract. 2019. PMID: 30292923 No abstract available.

9

Mobile health applications in clinical practice: pearls, pitfalls, and key considerations.

Cook VE, Ellis AK, Hildebrand KJ. Cook VE, et al. Among authors: hildebrand kj. Ann Allergy Asthma Immunol. 2016 Aug;117(2):143-9. doi: 10.1016/j.anai.2016.01.012. Ann Allergy Asthma Immunol. 2016. PMID: 27499542 Review. No abstract available.

10

Impact of supervised epinephrine autoinjector administration during food challenges on parent confidence.

Teoh T, Mill C, Wong T, Baerg I, Alexander A, Hildebrand KJ, Dean J, Kuzeljevic B, Chan ES. Teoh T, et al. Ann Allergy Asthma Immunol. 2016 May;116(5):467-9. doi: 10.1016/j.anai.2016.02.020. Ann Allergy Asthma Immunol. 2016. PMID: 27153741 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results